Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.59 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.59 |
| ▸ | PI4KA | P42356 | 2/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 9/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 9/20 | 0.46 |
| ▸ | CDK2 | P24941 | 9/20 | 0.46 |
| ▸ | CCNA2 | P20248 | 8/20 | 0.46 |
| ▸ | CCNA1 | P78396 | 8/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.46 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.45 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | PNP | P00491 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1924592 | 1.00 | PDPK1 (0.59) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Water SCHEMBL28083708 | 0.98 | PDPK1 (0.58) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL29514836 | 0.86 | PDPK1 (0.56) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL215054 | 0.86 | PDPK1 (0.56) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL11222102 | 0.85 | PDPK1 (0.63) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Barbital SCHEMBL2130352 | 0.85 | PDPK1 (0.44) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL17060283 | 0.84 | PDPK1 (0.61) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL1074970 | 0.83 | POLA1 (0.57) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL28299226 | 0.82 | POLA1 (0.53) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL9176120 | 0.82 | PDPK1 (0.59) | PDPK1GDAPI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235807-A1 | COMPOSITIONS AND METHODS TO IMPROVE GRAFT SURVIVAL | SOLID BIOSCIENCES, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025235404-A1 | FORMULATION FOR GENE THERAPY VECTORS | SOLID BIOSCIENCES, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4622983-A1 | METHOD OF SYNTHESIZING 4'-PHOSPHATE ANALOG NUCLEOTIDE PHOSPHORAMIDITE | Eli Lilly and Company (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4622982-A1 | METHODS OF SYNTHESIZING A TARGETING LIGAND-CONJUGATED NUCLEOTIDE PHOSPHORAMIDITE | Eli Lilly and Company (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4558641-A1 | METHODS FOR DETECTION AND REDUCTION OF SAMPLE PREPARATION-INDUCED METHYLATION ARTIFACTS | Guardant Health, Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-4555090-A1 | REGULATORY SYSTEM FOR EXPRESSION OF A GENE OF INTEREST IN A TARGET CELL AND METHOD OF USE THEREOF | Icahn School of Medicine at Mount Sinai (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025085519-A1 | R2 RETROTRANSPOSONS FOR GENE WRITING | TYPEWRITER THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-4504959-A1 | SUBSTRATE CLEAVAGE FOR NUCLEIC ACID SYNTHESIS | Twist Bioscience Corporation (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-4457364-A1 | METHODS OF NUCLEIC ACID SEQUENCING USING SURFACE-BOUND PRIMERS | Illumina, Inc. (US) | 2024-11-06 | — | — | EP | disclosed |
| EP-4409029-A1 | POLYNUCLEOTIDE SEQUENCING | Illumina, Inc. (US) | 2024-08-07 | — | — | EP | disclosed |
| WO-2024015729-A1 | REGULATORY SYSTEM FOR EXPRESSION OF A GENE OF INTEREST IN A TARGET CELL AND METHOD OF USE THEREOF | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2023201046-A1 | COMPOSITIONS AND METHOD FOR THE TREATMENT OF X-LINKED DYSTONIA PARKINSONISM | LIEBER INSTITUTE, INC. (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023196499-A1 | SUBSTRATE CLEAVAGE FOR NUCLEIC ACID SYNTHESIS | Twist Bioscience Corporation (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-4247968-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | Becton, Dickinson and Company (US) | 2023-09-27 | — | — | EP | disclosed |
| WO-2023164437-A1 | METHODS FOR TREATING CANCER PATIENTS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY BASED ON TEMPLATED INSERTIONS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-08-31 | — | — | WO | disclosed |
| EP-4229210-A1 | METHODS OF SYNTHESIZING OLIGONUCLEOTIDES USING TETHERED NUCLEOTIDES | Twist Bioscience Corporation (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023126457-A1 | METHODS OF NUCLEIC ACID SEQUENCING USING SURFACE-BOUND PRIMERS | ILLUMINA CAMBRIDGE LTD. (GB) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023052427-A1 | POLYNUCLEOTIDE SEQUENCING | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-04-06 | — | — | WO | disclosed |
| WO-2022109339-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022086866-A1 | METHODS OF SYNTHESIZING OLIGONUCLEOTIDES USING TETHERED NUCLEOTIDES | Twist Bioscience Corporation (US) | 2022-04-28 | — | — | WO | disclosed |